114 related articles for article (PubMed ID: 17954274)
1. Mutation of the PTEN gene in a human hepatic angiosarcoma.
Tate G; Suzuki T; Mitsuya T
Cancer Genet Cytogenet; 2007 Oct; 178(2):160-2. PubMed ID: 17954274
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation of the PTEN gene in a Japanese patient with Cowden syndrome and bilateral breast cancer.
Tate G; Suzuki T; Endo Y; Mitsuya T
Cancer Genet Cytogenet; 2008 Jul; 184(1):67-71. PubMed ID: 18558293
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA and PTEN mutations in adenoid cystic carcinoma of the breast metastatic to kidney.
Vranić S; Bilalović N; Lee LM; Kruslin B; Lilleberg SL; Gatalica Z
Hum Pathol; 2007 Sep; 38(9):1425-31. PubMed ID: 17669465
[TBL] [Abstract][Full Text] [Related]
4. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
[TBL] [Abstract][Full Text] [Related]
5. Active TGF-β signaling and decreased expression of PTEN separates angiosarcoma of bone from its soft tissue counterpart.
Verbeke SL; Bertoni F; Bacchini P; Oosting J; Sciot R; Krenács T; Bovée JV
Mod Pathol; 2013 Sep; 26(9):1211-21. PubMed ID: 23599148
[TBL] [Abstract][Full Text] [Related]
6. PTEN mutation spectrum in breast cancers and breast hyperplasia.
Yang J; Ren Y; Wang L; Li B; Chen Y; Zhao W; Xu W; Li T; Dai F
J Cancer Res Clin Oncol; 2010 Sep; 136(9):1303-11. PubMed ID: 20300775
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic profiling of the PI3K/PTEN pathway in sporadic breast cancer.
Nassiri I; Faghihi M; Tavassoli M
Iran Biomed J; 2009 Apr; 13(2):79-86. PubMed ID: 19471547
[TBL] [Abstract][Full Text] [Related]
8. Activation of Akt independent of PTEN and CTMP tumor-suppressor gene mutations in epilepsy-associated Taylor-type focal cortical dysplasias.
Schick V; Majores M; Engels G; Spitoni S; Koch A; Elger CE; Simon M; Knobbe C; Blümcke I; Becker AJ
Acta Neuropathol; 2006 Dec; 112(6):715-25. PubMed ID: 17013611
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase regulatory subunit 1 and phosphatase and tensin homolog as therapeutic targets in breast cancer.
Dirican E; Akkiprik M
Tumour Biol; 2017 Mar; 39(3):1010428317695529. PubMed ID: 28351303
[TBL] [Abstract][Full Text] [Related]
10. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
11. Genetic changes in the PTEN gene and their association with breast cancer in Pakistan.
Baig RM; Mahjabeen I; Sabir M; Masood N; Hafeez S; Malik FA; Kayani MA
Asian Pac J Cancer Prev; 2011; 12(10):2773-8. PubMed ID: 22320991
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients.
Bae JJ; Rho JW; Lee TJ; Yun SS; Kim HJ; Choi JH; Jeong D; Jang BC; Lee TY
Oncol Rep; 2007 Oct; 18(4):1007-13. PubMed ID: 17786367
[TBL] [Abstract][Full Text] [Related]
13. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2.
Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP
Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.
Pérez-Tenorio G; Alkhori L; Olsson B; Waltersson MA; Nordenskjöld B; Rutqvist LE; Skoog L; Stål O
Clin Cancer Res; 2007 Jun; 13(12):3577-84. PubMed ID: 17575221
[TBL] [Abstract][Full Text] [Related]
15. PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
Day FL; Jorissen RN; Lipton L; Mouradov D; Sakthianandeswaren A; Christie M; Li S; Tsui C; Tie J; Desai J; Xu ZZ; Molloy P; Whitehall V; Leggett BA; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Busam D; Zhao Q; Strausberg RL; Gibbs P; Sieber OM
Clin Cancer Res; 2013 Jun; 19(12):3285-96. PubMed ID: 23633456
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the human PTEN gene.
Bonneau D; Longy M
Hum Mutat; 2000; 16(2):109-22. PubMed ID: 10923032
[TBL] [Abstract][Full Text] [Related]
17. Aberrant PTEN, PIK3CA, pMAPK, and TP53 expression in human scalp and face angiosarcoma.
Wan H; Zhang D; Hu W; Xie Z; Du Q; Xia Q; Wen T; Jia H
Medicine (Baltimore); 2021 Jul; 100(30):e26779. PubMed ID: 34397726
[TBL] [Abstract][Full Text] [Related]
18. Genetic profile of PTEN gene in Indian oral squamous cell carcinoma primary tumors.
Shah S; Jajal D; Mishra G; Kalia K
J Oral Pathol Med; 2017 Feb; 46(2):106-111. PubMed ID: 27381359
[TBL] [Abstract][Full Text] [Related]
19. PTEN/MMAC1 mutations in hepatocellular carcinomas.
Yao YJ; Ping XL; Zhang H; Chen FF; Lee PK; Ahsan H; Chen CJ; Lee PH; Peacocke M; Santella RM; Tsou HC
Oncogene; 1999 May; 18(20):3181-5. PubMed ID: 10340391
[TBL] [Abstract][Full Text] [Related]
20. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
